PADnet Xpress Passes Electrical Safety Certification for Home Use
Advances Platform as Technology of Choice for In-Home Wellness Assessments
Today Biomedix announced it has successfully received an important electrical safety certification required for in-home health screenings.
PADnet Xpress, the latest technology from Biomedix designed for peripheral artery disease (PAD) identification, has successfully passed IEC 60601-1-11 testing, confirming it is safe and appropriate for home use.
“With the COVID-19 pandemic, a number of our healthcare providers anticipate that going forward, more services will be delivered in the home,” said Rich Delperdang, Chief Growth Officer of Biomedix. “Given our focus on safety, both for our customers, and their patients and members, we made the decision to invest in this enhanced electrical safety certification.”
To find out more about PADnet Xpress, please contact Rich Delperdang, Chief Growth Officer at Biomedix, at firstname.lastname@example.org.
Biomedix is a provider of front-line diagnostic solutions for delivering value-based care. Biomedix Xchange is a population health solution that centralizes data for analyzing population health across multiple chronic conditions. For more information, visit Biomedix.com.
About PADnet & PADnet Xpress
Biomedix is the maker of PADnet, the market leader in front-line diagnostics for peripheral vascular disease. PADnet is the only diagnostic device that can support the identification of PAD and chronic venous insufficiency (CVI) through a unique collaborative care model. PADnet Xpress represents the latest technology for quick and accurate PAD detection, custom-designed for value-based care, including Medicare Advantage Organizations (MAOs).